ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Cell Cycle >Aurora Kinase Inhibitors >MLN-8237

MLN-8237

MLN-8237 Structure
CAS No.
1028486-01-2
Chemical Name:
MLN-8237
Synonyms
Alisertib;Alisertib (MLN8237);MLN8237 (Alisertib);CS-277;MLN-823;MLN-8237;MLN-8237; MLN 8237;MLN-8237 USP/EP/BP;13C,2H3]-Alisertib;ALIERTIB (MLN 8237)
CBNumber:
CB62510095
Molecular Formula:
C27H20ClFN4O4
Molecular Weight:
518.92
MOL File:
1028486-01-2.mol
Modify Date:
2023/6/8 9:03:09

MLN-8237 Properties

Boiling point 729.1±70.0 °C(Predicted)
Density 1.43±0.1 g/cm3(Predicted)
storage temp. -20°C
solubility Soluble in DMSO (up to 5 mg/ml)
form solid
pka 4.07±0.10(Predicted)
color Off-white
Stability Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.

SAFETY

Risk and Safety Statements

Signal word  Warning
Hazard statements  H320
Precautionary statements  P264-P305+P351+P338-P337+P313
NFPA 704
0
1 0

MLN-8237 Chemical Properties,Uses,Production

Chemical Properties

Off-White Solid

Uses

An Aurora kinase inhibitor, used to treat patients with advanced solid tumors.

Global( 184)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
Capot Chemical Co.,Ltd. 571-85586718 +8613336195806 China 29798 60 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32836 60 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29888 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry
Chongqing Chemdad Co., Ltd +86-023-6139-8061 +86-86-13650506873 China 39916 58 Inquiry
CONIER CHEM AND PHARMA LIMITED +8618523575427 China 49392 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 +1-00000000000 United States 19892 58 Inquiry

MLN-8237 Spectrum

Benzoic acid, 4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxy- MLN-8237 4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid alisertib (auroura A kinase inhibitor) Fluorocyclopentenylcytosine ALISERTIB (MLN8237);MLN 8237; MLN8237;MLN-8237 4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-meth MLN-823 MLN-8237 4-((9-chloro-7-(2-fluoro-6-Methoxyphenyl)-5H-benzo[c]pyriMido[4,5-e]azepin-2-yl)aMino)-2-Methoxybenzoic acid 4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid 4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-methoxy MLN 8237 (Contain 10% DMSO) MLN-8237; MLN 8237 CS-277 ALIERTIB (MLN 8237) ALISERTIB;MLN 8237;MLN-8237 MLN-8237 USP/EP/BP MLN8237 (Alisertib) Alisertib Alisertib (MLN8237) 13C2,2H3,15N2]-Alisertib 13C,2H3]-Alisertib MLN8237 Alisertib MLN-8237 arrest,myeloma,cytotoxicity,MLN-8237,spindle,Alisertib,inhibit,mitotic,Autophagy,Aurora Kinase,cancer,multiple,Inhibitor,MLN8237,cell-cycle,Apoptosis 4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-methoxy MLN 8237 (Contain 10% DMSO) 1028486-01-2 C27H20ClFN4O4 Inhibitor Inhibitors Intermediates & Fine Chemicals Pharmaceuticals API